Table 5 Overall survival and progression-free survival dating from enrollment and, separately, first injection: median and six-month intervals (data cut off 31 Dec 21)
| Â | From enrollment | From first injection | ||
|---|---|---|---|---|
OS | PFS | OS | PFS | |
N (censored) | 60 (21) | 60 (10) | 57 (19) | 57 (9) |
Median (months) | 16.0 | 10.4 | 14.0 | 8.5 |
95% CI on Median | 12.9:20.6 | 8.6:11.7 | 10.1:18.3 | 6.5:9.1 |
Percent Surviving* (remaining at risk at the indicated time) | ||||
6 months | 89.5%(51) | 77.7%(45) | 87.5%(49) | 69.7%(39) |
12 months | 70.2%(40) | 34.5%(20) | 55.4%(31) | 26.8%(15) |
18 months | 44.5%(20) | 20.2%(9) | 38.5%(16) | 16.1%(6) |
24 months | 26.8%(9) | 12.6%(5) | 25.2%(7) | 10.0%(3) |